Atlas Trials

Nintedanib (Vargatef®) Plus Docetaxel in Second Line of Treatment in Patients With Lung Cancer

Clinical trial NCT02531737 · COMPLETED

Trial details

NCT number
NCT02531737
Sponsor
University Hospital, Limoges
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Lung Neoplasms
Start date
2015-09-01
Primary completion
2020-09-26
Enrollment
59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.